CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.
<h4>Background</h4>The cyclic nucleotides cyclic adenosine-3',5'-monophosphate (cAMP) and cyclic guanosine-3',5'-monophosphate (cGMP) are important second messengers and are potential biomarkers for Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) an...
Guardado en:
Autores principales: | Patrick Oeckl, Petra Steinacker, Stefan Lehnert, Sarah Jesse, Hans A Kretzschmar, Albert C Ludolph, Markus Otto, Boris Ferger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ca108ae1354458b855b29fa89919062 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rhodopsin-cyclases for photocontrol of cGMP/cAMP and 2.3 Å structure of the adenylyl cyclase domain
por: Ulrike Scheib, et al.
Publicado: (2018) -
Blue fluorescent cGMP sensor for multiparameter fluorescence imaging.
por: Yusuke Niino, et al.
Publicado: (2010) -
Creutzfeldt–Jakob disease with unusual presentation of peripheral neuropathy and ophthalmoplegia
por: Mais Arwani, et al.
Publicado: (2018) -
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience
por: Joanna Balcerek, et al.
Publicado: (2021) -
Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures
por: Hervé Cassard, et al.
Publicado: (2020)